Inhibition of osteosarcoma by European Mistletoe derived val-miR218

Abstract

Aim: In recent years, there has been a growing interest in the therapeutic potential of plant-derived miRNAs, which have been considered new bioactive ingredients in medicinal plants. Viscum album L., commonly used as an adjuvant cancer therapy in central Europe, contains a large number of miRNAs associated with human diseases such as cancer, cardiovascular diseases, and neurological disorders. This study aimed to investigate whether mistletoe miRNAs, specifically val-miR218, exert anti-cancer activity against osteosarcoma.

Methods: The anti-cancer effects of miRNAs from V. album L. were evaluated. The targets of val-miR218 were identified by RNA-seq. The mRNA and protein expression of the targets was confirmed by RT-qPCR and western blot analyses. The interaction between the val-miR218 and miRNA recognition elements (MREs) was validated by the dual-luciferase assay. The inhibitory effect of val-miR218 against osteosarcoma was investigated in vivo.

Results: Among these abundant miRNAs in V. album L., val-miR218 showed high potential anti-cancer effects against osteosarcoma. To clarify its molecular mechanism of action, we sequenced val-miR218 associated RNAs and their down-regulated RNAs. As a result, 61 genes were considered the direct targets of val-miR218. Interestingly, these targets were related to essential cellular functions such as cell cycle, DNA replication, and cell morphology, suggesting that val-miR218 significantly inhibited cell growth and arrested osteosarcoma cells in G0/G1 phase by influencing basic cell activities. Mistletoe extracellular vesicles offered val-miR218 adequate protection and facilitated the uptake of val-miR281 by human cells. Moreover, val-miR218 showed significant anti-tumor effects in vivo.

Conclusion: This study demonstrated the significant potential of val-miR218 regarding proliferation inhibition in various tumor cell lines in vitro and for osteosarcoma in vivo. Due to the increasing problems during chemotherapy, new therapeutic approaches are becoming more critical. The significant anti-cancer effects of medicinal plants derived miRNAs indicate a promising therapeutic strategy for treating cancer.

Keywords

miRNAs / medicinal plants / mistletoe / Viscum album L / osteosarcoma

References

[1] Zhu Y,Wang X.RNA-based therapeutics: an overview and prospectus.Cell Death Dis2022;13:644 PMCID:PMC9308039

[2] Nielsen AF,Bozzoni I.Best practice standards for circular RNA research.Nat Methods2022;19:1208-20 PMCID:PMC9759028

[3] Voinnet O.Origin, biogenesis, and activity of plant microRNAs.Cell2009;136:669-87

[4] Friedman RC,Burge CB.Most mammalian mRNAs are conserved targets of microRNAs.Genome Res2009;19:92-105 PMCID:PMC2612969

[5] Chen X.Plant and animal small RNA communications between cells and organisms.Nat Rev Mol Cell Biol2022;23:185-203 PMCID:PMC9208737

[6] Li C,Xu H.Roles and mechanisms of exosomal non-coding RNAs in human health and diseases.Signal Transduct Target Ther2021;6:383 PMCID:PMC8578673

[7] Sohel MH.Extracellular/circulating micrornas: release mechanisms, functions and challenges.Achievements in the Life Sciences2016;10:175-86

[8] Mori MA,Garcia-Martin R,Kahn CR.Extracellular miRNAs: from biomarkers to mediators of physiology and disease.Cell Metab2019;30:656-73 PMCID:PMC6774861

[9] Makarova J,Shkurnikov M.Extracellular miRNAs and cell-cell communication: problems and prospects.Trends Biochem Sci2021;46:640-51

[10] Rupaimoole R.MicroRNA therapeutics: towards a new era for the management of cancer and other diseases.Nat Rev Drug Discov2017;16:203-22

[11] Diener C,Meese E.Emerging concepts of miRNA therapeutics: from cells to clinic.Trends Genet2022;38:613-26

[12] Moran Y,Praher D.The evolutionary origin of plant and animal microRNAs.Nat Ecol Evol2017;1:27 PMCID:PMC5435108

[13] Wynant N,Vanden Broeck J.The evolution of animal Argonautes: evidence for the absence of antiviral AGO Argonautes in vertebrates.Sci Rep2017;7:9230 PMCID:PMC5569025

[14] Singh RK,Baldwin IT.Molecular evolution and diversification of the Argonaute family of proteins in plants.BMC Plant Biol2015;15:23 PMCID:PMC4318128

[15] Zhang L,Chen X.Erratum: exogenous plant MIR168a specifically targets mammalian LDLRAP1: evidence of cross-kingdom regulation by microRNA.Cell Res2012;22:273-4 PMCID:PMC3351925

[16] Zhou Z,Liu J.Honeysuckle-encoded atypical microRNA2911 directly targets influenza A viruses.Cell Res2015;25:39-49 PMCID:PMC4650580

[17] Chin AR,Somlo G.Cross-kingdom inhibition of breast cancer growth by plant miR159.Cell Res2016;26:217-28 PMCID:PMC4746606

[18] Chen X,Chu Q.Large-scale identification of extracellular plant miRNAs in mammals implicates their dietary intake.PLoS One2021;16:e0257878 PMCID:PMC8480717

[19] Zhou LK,Jiang XM.Absorbed plant MIR2911 in honeysuckle decoction inhibits SARS-CoV-2 replication and accelerates the negative conversion of infected patients.Cell Discov2020;6:54 PMCID:PMC7406496

[20] Gismondi A,Monteleone V,Di Marco G.Plant miR171 modulates mTOR pathway in HEK293 cells by targeting GNA12.Mol Biol Rep2021;48:435-49

[21] Zhang S,Hou D.Plant-derived RNAi therapeutics: a strategic inhibitor of HBsAg.Biomaterials2019;210:83-93

[22] Li M,Wang R. Plant MIR156 regulates intestinal growth in mammals by targeting the Wnt/β-catenin pathway. American Journal of Physiology-Cell Physiology 2019;317:C434-48.

[23] Li M,He JJ.Plant MIR167e-5p inhibits enterocyte proliferation by targeting β-catenin.Cells2019;8:1385 PMCID:PMC6912825

[24] Horneber MA,Huber R,Rostock M.Mistletoe therapy in oncology.Cochrane Database Syst Rev2008;2008:CD003297 PMCID:PMC7144832

[25] Xie W,Melzig MF.Identification of viscum album L. miRNAs and prediction of their medicinal values.PLoS One2017;12:e0187776 PMCID:PMC5675405

[26] Xie W.The Stability of medicinal plant microRNAs in the herb preparation process.Molecules2018;23:919 PMCID:PMC6016954

[27] Steele ML,Happe A,Matthes H.Use and safety of intratumoral application of European mistletoe (Viscum album L) preparations in Oncology.Integr Cancer Ther2015;14:140-8

[28] Marvibaigi M,Amini N,Jaganathan SK.Preclinical and clinical effects of mistletoe against breast cancer.Biomed Res Int2014;2014:785479 PMCID:PMC4127267

[29] Kleinsimon S,Rolff J.GADD45A and CDKN1A are involved in apoptosis and cell cycle modulatory effects of viscumTT with further inactivation of the STAT3 pathway.Sci Rep2018;8:5750 PMCID:PMC5893628

[30] Tan SM,Jin J.Sequencing of captive target transcripts identifies the network of regulated genes and functions of primate-specific miR-522.Cell Rep2014;8:1225-39

[31] Zhuang X,Mu J.Ginger-derived nanoparticles protect against alcohol-induced liver damage.J Extracell Vesicles2015;4:28713. [PMID: 26610593] PMCID:PMC4662062

[32] Lal A,Altschuler G.Capture of microRNA-bound mRNAs identifies the tumor suppressor miR-34a as a regulator of growth factor signaling.PLoS Genet2011;7:e1002363 PMCID:PMC3213160

[33] Mirabello L,Savage SA.International osteosarcoma incidence patterns in children and adolescents, middle ages and elderly persons.Int J Cancer2009;125:229-34 PMCID:PMC3048853

[34] Weiner BE,Dattilo BM,Fanning E.An iron-sulfur cluster in the C-terminal domain of the p58 subunit of human DNA primase.J Biol Chem2007;282:33444-51

[35] Wang T,Jiang Y.PRIM2 promotes cell cycle and tumor progression in p53-mutant lung cancer.Cancers2022;14:3370 PMCID:PMC9320259

[36] Xu X,Hua X,He R.Stable inheritance of H3.3-containing nucleosomes during mitotic cell divisions.Nat Commun2022;13:2514 PMCID:PMC9076889

[37] Edmond V,Gout S,Gazzeri S.A new function of the splicing factor SRSF2 in the control of E2F1-mediated cell cycle progression in neuroendocrine lung tumors.Cell Cycle2013;12:1267-78 PMCID:PMC3674091

[38] Panvert M,Arnold L.Cdc123, a cell cycle regulator needed for eIF2 assembly, is an ATP-grasp protein with unique features.Structure2015;23:1596-608

[39] Chen Y,Hirschberg J.The amyloid precursor protein-binding protein APP-BP1 drives the cell cycle through the S-M checkpoint and causes apoptosis in neurons.J Biol Chem2000;275:8929-35

[40] Olaizola P,Fernandez-Barrena MG.Targeting NAE1-mediated protein hyper-NEDDylation halts cholangiocarcinogenesis and impacts on tumor-stroma crosstalk in experimental models.J Hepatol2022;77:177-90

[41] Magnusson K,Rydén L.ANLN is a prognostic biomarker independent of Ki-67 and essential for cell cycle progression in primary breast cancer.BMC Cancer2016;16:904 PMCID:PMC5116155

[42] Fischer M,Sohr S.p53 and cell cycle dependent transcription of kinesin family member 23 (KIF23) is controlled via a CHR promoter element bound by DREAM and MMB complexes.PLoS One2013;8:e63187 PMCID:PMC3641139

[43] Wang Q,Hu J.Nestin Is required for spindle assembly and cell-cycle progression in glioblastoma cells.Mol Cancer Res2021;19:1651-65 PMCID:PMC8492506

[44] Kim S,Bubenshchikova E.Nde1-mediated inhibition of ciliogenesis affects cell cycle re-entry.Nat Cell Biol2011;13:351-60 PMCID:PMC3077088

[45] Tabatabaeian H,Ramos A,Sudol M.The emerging roles of WBP2 oncogene in human cancers.Oncogene2020;39:4621-35 PMCID:PMC7286818

[46] Song H,Xie D.WBP2 downregulation inhibits proliferation by blocking YAP Transcription and the EGFR/PI3K/Akt signaling pathway in triple negative breast cancer.Cell Physiol Biochem2018;48:1968-82

[47] Barr AR,Heldt FS.DNA damage during S-phase mediates the proliferation-quiescence decision in the subsequent G1 via p21 expression.Nat Commun2017;8:14728 PMCID:PMC5364389

[48] Deng C,Harper JW,Leder P.Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control.Cell1995;82:675-84

[49] Shen G,Chen C,Kong AN.p53-independent G1 cell cycle arrest of human colon carcinoma cells HT-29 by sulforaphane is associated with induction of p21CIP1 and inhibition of expression of cyclin D1.Cancer Chemother Pharmacol2006;57:317-27

[50] Jeong JH,Park KK,Magae J.p53-independent induction of G1 arrest and p21WAF1/CIP1 expression by ascofuranone, an isoprenoid antibiotic, through downregulation of c-Myc.Mol Cancer Ther2010;9:2102-13

[51] Nazaruk J.Phytochemical profile and therapeutic potential of Viscum album L.Nat Prod Res2016;30:373-85

[52] Rutter BD.Growing pains: addressing the pitfalls of plant extracellular vesicle research.New Phytol2020;228:1505-10

[53] Pinedo M,de Marcos Lousa C.A call for Rigor and standardization in plant extracellular vesicle research.J Extracell Vesicles2021;10:e12048 PMCID:PMC8077130

[54] Woith E.Extracellular vesicles from fresh and dried plants-simultaneous purification and visualization using gel electrophoresis.Int J Mol Sci2019;20:357 PMCID:PMC6359398